Verve Therapeutics, Inc. VERV
11.13 0.00 (+0.00%)
At closeJul 25, 2025, 4:00 PM EDT
11.13 Day range 11.13
52-week range unavailable
- YTD
- +97.34%
- 1 year
- +57.20%
News
247wallst.com Three Biotechs That Are Top Takeover Targets Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious: Mounjaro revenue jumped 125% to $8.66 billion last quarter, the company raised…
benzinga.com What's Happening With French Biotech Abivax Stock On Wednesday? Abivax shares rise on renewed takeover speculation tied to Eli Lilly following strong Phase 3 trial results.
prnewswire.com Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk INDIANAPOLIS , July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a…
prnewswire.com Lilly and Verve announce expiration of Verve tender offer INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to purchase all of the issued and…
marketbeat.com 3 Bullish Biotech Stocks With Explosive Growth Trends Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience long periods of nothing much happening, interrupted by periods of sharp…
fool.com Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week Shares in Verve Therapeutics (VERV -0.54%) soared 80.5% this week on the news of an agreement for Eli Lilly (LLY -2.60%) to acquire Verve. The deal centers on an exciting cardiovascular health…
globenewswire.com $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Verve Therapeutics, Inc. (NASDAQ: VERV) NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and…
businesswire.com VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of…
benzinga.com Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.
zacks.com Gene-Editing Stocks Gain on LLY-VERV Deal Announcement LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.
zacks.com Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's pipeline.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
businesswire.com VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Verve Therapeutics, Inc. (NASDAQ: VERV) to Eli Lilly and Company is fair to Verve…
fool.com Why Verve Therapeutics Stock Is Skyrocketing Today Shares of Verve Therapeutics (VERV 76.24%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tuesday.
benzinga.com Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday 
schaeffersresearch.com Biotech Stock Surging on Billion-Dollar Buyout Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly (LLY) will buy the company for $10.50 per share, or roughly $1.3 billion.
investors.com Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing company for up to $1.3 billion.
benzinga.com Top 3 Health Care Stocks That Are Ticking Portfolio Bombs 
businesswire.com Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Verve (Nasdaq: VERV) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli Lilly. Click here to…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
wsj.com Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a potential treatment for cardiovascular disease to its portfolio.
reuters.com Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday.
prnewswire.com Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease Lilly's established capabilities in…
benzinga.com Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
barrons.com Eli Lilly Close to $1.3 Billion Bid for Biotech, Says Report. Verve Therapeutics Stock Soars 80%. A report said the two pharmaceutical companies are in advance talks.
proactiveinvestors.co.uk Eli Lilly lining up $1.3bn swoop for cholesterol specialist Verve Eli Lilly and Co (NYSE:LLY) is in advanced discussions to acquire Verve Therapeutics in a deal worth up to $1.3 billion, according to the Financial Times. The proposed terms include a nearly $1…
reuters.com Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.
benzinga.com Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday (CORRECTED) 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally 
benzinga.com Nasdaq Down Over 1%; VivoPower International Shares Spike Higher U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500…- benzinga.com Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
- benzinga.com Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS…
- benzinga.com Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.
- benzinga.com Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for…
benzinga.com Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 179 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 99 stocks hit new 52-week lows.
benzinga.com Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.- benzinga.com Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
benzinga.com Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday Gainers- benzinga.com Dow Surges 400 Points; Crude Oil Down 1% U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
- benzinga.com Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 Upgrades
- benzinga.com Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday Gainers
- benzinga.com Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session Gainers